Literature DB >> 26279699

Brain Metastasis from Neuroblastoma Depicted by (18)F-DOPA PET/CT.

Arnoldo Piccardo1, Giovanni Morana2, Michela Massollo1, Marco Pescetto3, Massimo Conte4, Alberto Garaventa4.   

Abstract

Entities:  

Year:  2015        PMID: 26279699      PMCID: PMC4532683          DOI: 10.1007/s13139-015-0322-8

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


× No keyword cloud information.
  9 in total

1.  Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

2.  18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.

Authors:  Egesta Lopci; Arnoldo Piccardo; Cristina Nanni; Vania Altrinetti; Alberto Garaventa; Andrea Pession; Angelina Cistaro; Arturo Chiti; Giampiero Villavecchia; Stefano Fanti
Journal:  Clin Nucl Med       Date:  2012-04       Impact factor: 7.794

3.  Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Egesta Lopci; Massimo Conte; Luca Foppiani; Stefania Sorrentino; Giovanni Morana; Mehrdad Naseri; Angelina Cistaro; Giampiero Villavecchia; Stefano Fanti; Alberto Garaventa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

4.  Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

Authors:  Ruth Ladenstein; Dominique Valteau-Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Geneviève Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck-Popovic; Günter Schreier; David Machin; Ulrike Pötschger; Andrew Pearson
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

5.  Imaging of metastatic CNS neuroblastoma.

Authors:  Nicholas D'Ambrosio; John K Lyo; Robert J Young; Sophia S Haque; Sasan Karimi
Journal:  AJR Am J Roentgenol       Date:  2010-05       Impact factor: 3.959

6.  Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.

Authors:  Katherine K Matthay; Hervé Brisse; Dominique Couanet; Jerome Couturier; Jean Bénard; Veronique Mosseri; Véronique Edeline; Jean Lumbroso; Dominique Valteau-Couanet; Jean Michon
Journal:  Cancer       Date:  2003-07-01       Impact factor: 6.860

Review 7.  PET/CT imaging in neuroblastoma.

Authors:  A Piccardo; E Lopci; M Conte; L Foppiani; A Garaventa; M Cabria; G Villavecchia; S Fanti; A Cistaro
Journal:  Q J Nucl Med Mol Imaging       Date:  2013-03       Impact factor: 2.346

8.  Characterization of neuroblastic tumors using 18F-FDOPA PET.

Authors:  Meng-Yao Lu; Yen-Lin Liu; Hsiu-Hao Chang; Shiann-Tarng Jou; Yung-Li Yang; Kai-Hsin Lin; Dong-Tsamn Lin; Ya-Ling Lee; Hsinyu Lee; Pei-Yi Wu; Tsai-Yueh Luo; Lie-Hang Shen; Shiu-Feng Huang; Yung-Feng Liao; Wen-Ming Hsu; Kai-Yuan Tzen
Journal:  J Nucl Med       Date:  2012-12-04       Impact factor: 10.057

9.  Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Manlio Cabria; Angelina Cistaro; Alberto Garaventa; Giampiero Villavecchia
Journal:  Clin Nucl Med       Date:  2014-01       Impact factor: 7.794

  9 in total
  1 in total

1.  Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.

Authors:  Giovanni Morana; Matteo Puntoni; Maria Luisa Garrè; Michela Massollo; Egesta Lopci; Merhdad Naseri; Mariasavina Severino; Domenico Tortora; Andrea Rossi; Arnoldo Piccardo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-25       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.